Fig. 4: Durability of vaccination-induced SARS-CoV-2 vaccination-induced immunity against Omicron BA.2.

Schematic highlighting the durability of SARS-CoV-2 vaccination-induced antibody response in naive (blue) vs convalescent (red) adults shown as percent seropositivity of neutralization titers and spike antibody affinity against SARS-CoV-2 Omicron BA.2 following second and third mRNA vaccination.